ArticleCureus2026
Nephrocalcinosis Following Roux-en-Y Gastric Bypass Secondary to Suspected Enteric Hyperoxaluria: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nephrocalcinosis refers to the deposition of calcium oxalate or calcium phosphate in the kidney, most commonly within the renal medulla, and is frequently linked with underlying metabolic abnormalities. Roux-en-Y gastric bypass (RYGB) is a well-established risk factor for enteric hyperoxaluria secondary to fat malabsorption, thereby increasing the risk of nephrolithiasis, oxalate nephropathy, and nephrocalcinosis. Despite this association, nephrocalcinosis following RYGB remains an uncommon and underrecognized clinical entity. A 36-year-old male with a history of complicated peptic ulcer disease, multiple prior abdominal surgeries, and previous RYGB presented with acute abdominal pain and distention. Laboratory evaluation revealed an elevated creatinine of 2.27 mg/dL, a suppressed parathyroid hormone level of 6.3 pg/mL, and hypocalcemia with serum calcium of 8.1 mg/dL. Imaging studies revealed bilateral renal medullary calcifications, consistent with nephrocalcinosis. Given the patient's history of RYGB, chronic pancreatitis, multiple GI surgeries, and evidence of chronic malnutrition, chronic malabsorptive physiology leading to enteric hyperoxaluria was hypothesized to be the most plausible explanation. However, measurements of 24-hour urinary oxalate, calcium, citrate, and vitamin D, as well as a renal biopsy, were not obtained, thereby precluding definitive confirmation of this proposed mechanism. This case highlights the importance of considering metabolic and renal complications in patients with complex GI disease following bariatric surgery and emphasizes the role of comprehensive metabolic evaluation and renal imaging in improving early recognition, diagnostic accuracy, and long-term kidney outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.